JD

John De Koning

Partner at EQT Life Sciences

Amsterdam, North Holland

Overview

John de Koning is a Partner at EQT Life Sciences (formerly LSP) in Amsterdam, North Holland. With a background in oncology and biotechnology, he has served on the boards of companies such as Visus Therapeutics, VarmX, and eTheRNA Immunotherapies, and has made strategic investments in companies like Tubulis and Merus.

Work Experience

EL

EQT Life Sciences

Partner
2022 - Current
EQT Life Sciences (formerly LSP), is one of Europe’s largest and most experienced healthcare investment firms, targeting innovative life sciences and health care companies.

VT

Visus Therapeutics, Inc.

Board Member
2021

Visus Therapeutics is a clinical-stage company developing innovative medicines.

Raised $56,000,000.00 from Johnson & Johnson Innovation – JJDC and EQT Life Sciences.

visustx.com

x

xilis

Board Observer
2021

Xilis is an oncology and precision health company that provides technologies to diagnoses cancer.

Raised $92,000,000.00 from FPV Ventures, EQT, Two Sigma Ventures, Mubadala Capital Ventures, Google Ventures, Alix Ventures, Alexandria Venture Investments, Felicis, Duke Angel Network and Catalio Capital Management.

xilis.net

V

VarmX

Board Member
2020

XT

XyloCor Therapeutics, Inc.

Board Observer
2018

XyloCor Therapeutics is a bio-pharmaceutical company intended to develop gene therapy for people with advanced coronary artery disease.

Raised $39,600,000.00 from Longwood Fund, EQT Life Sciences, Sofinnova Investments, Lumira Ventures, Fountain Healthcare Partners, EQT Life Sciences and Sofinnova Investments.

xylocor.com

eI